Ultrasound-Based TestingFibrosis Assessment
Imaging-Based Diagnostic Tests • Diagnostic Tests With Ultrasound

Diagnostic Performance of Ultrasound-Based Elastography

Published biopsy-validated cutoffs, sensitivities, and specificities for moderate fibrosis (>=F2), advanced fibrosis (>=F3), and cirrhosis (F4).

What This Means for Patients

Why do studies list several different kPa cutoffs for cirrhosis (F4), like 13.1 kPa vs 20.9 kPa? It comes down to the trade-off between catching almost every case (high sensitivity at lower cutoffs, with more false alarms) versus being 90% certain cirrhosis is truly present (high specificity at higher cutoffs). That is why your hepatologist interprets a borderline stiffness number alongside blood scores like FIB-4 or ELF rather than treating a single kPa cutoff as an absolute verdict.

LSM by VCTE™ or FibroScan®

Stage Cutoff, kPa Sens, % (95% CI)a Spec, % (95% CI)b
≥F2 >8.21 71 (64–77) 70 (62–77)
≥F3 >9.71 71 (62–78) 75 (69–80)
F4 >13.12 89 (NR) 86 (NR)
>13.61 85 (69–95) 79 (74–83)
>14.92 69 (NR) 90 (NR)
>20.91 59 (41–75) 90 (86–93)

2D-SWE3

Stage Cutoff, kPa Sens, % (95% CI)a Spec, % (95% CI)b
≥F2 ≥7.1 94 (85–100) 52 (23–80)
≥F3 ≥9.2 93 (85–100) 81 (71–89)
F4 ≥13 75 (45–98) 88 (78–96)

pSWE4

Stage Cutoff, m/s Sens, % (95% CI)a Spec, % (95% CI)b
≥F2 1.2 85–90c 36–90c
≥F3 1.5 70 (58–80) 92 (89–94)
F4 2 75–90c 67–90c